Early Loading of Dental Implants; A Prospective Study in the Mandibular First Molar Area.

Sponsor
Loma Linda University (Other)
Overall Status
Unknown status
CT.gov ID
NCT02836964
Collaborator
(none)
24
1
2
12.9
1.9

Study Details

Study Description

Brief Summary

To evaluate the clinical success, stability, radiographic bone level changes and peri-implants soft tissue parameter of the SLActive surface implant supporting single crowns restorations in early loading in the mandibular first molar region.

Condition or Disease Intervention/Treatment Phase
  • Device: Dental Implant
N/A

Detailed Description

The human clinical trial will be designed as a longitudinal prospective study. A total of 24 titanium implants with a modified SLA surface (BLT SLActive®, Institute Straumann AG, Basel, Switzerland) will be placed in the mandibular first molar. 12 for the control group and for the 12 test group.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
24 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
Early Loading of Dental Implants; A Prospective Study in the Mandibular First
Actual Study Start Date :
Feb 1, 2017
Anticipated Primary Completion Date :
Feb 1, 2018
Anticipated Study Completion Date :
Mar 1, 2018

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Loading of Dental Implants after 4 weeks

A total of 12 titanium implants with a modified SLA surface (BLT SLActive®, Institute Straumann AG, Basel, Switzerland) will be placed in the mandibular first molar. for this group. After 4 weeks definitive crown will be placed.

Device: Dental Implant
Dental implant

Active Comparator: Loading of Dental Implants after 3 months

A total of 12 titanium implants with a modified SLA surface (BLT SLActive®, Institute Straumann AG, Basel, Switzerland) will be placed in the mandibular first molar for this group. After 3 months definitive crown will be placed

Device: Dental Implant
Dental implant

Outcome Measures

Primary Outcome Measures

  1. marginal bone level changes by using periodical radiography. [assessment of marginal bone level (MBL) will be made at the time of implant placement and after 6 months]

    Standardized radiographs using customized jig and long cone paralleling technique, using Rinn Film holders (Dentsply, Germany) for assessment of marginal bone level (MBL) will be made at the time of implant placement, as well as at 3 and 6 months 3. Changes in interproximal crestal bone levels will be measured and recorded using NIH Image Program Software(http:/rsb.info.nih.gov/nih-image)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Patients aged 18 years or older.

  2. Willingness to comply with all study requirements.

  3. Partially edentulous in the in mandibular first molar with presence of the mandibular second molar

  4. Patients of ASA I and ASA II group. No relevant medical conditions such as uncontrolled diabetes mellitus, osteoporosis, malignancies, irradiation and blood dyscrasias.

  5. Free from soft tissue mucosal lesions, caries, and active periodontitis at the time of implant insertion.

  6. Sufficient alveolar bone volume at the implant recipient site at the time of the insertion.

  7. Adequate oral hygiene. Full-mouth plaque score (FMPS) (O'Leary et al. 1972) full-mouth bleeding score (FMBS) (Ainamo & Bay 1975) record as the percentage of surfaces, four per each tooth, patients need to have controlled their periodontal conditions (FMPS 20%, FMBS 20%).

Exclusion Criteria:
  1. Pregnant or lactating females.

  2. Systemic disease likely to compromise implant surgery; uncontrolled diabetes mellitus.

  3. History of irradiation in the head and neck area.

  4. Smoking.

  5. Untreated periodontitis.

  6. Alcohol or drug abuse.

  7. History of Intravenous Bisphosphonate.

  8. Previously augmented or tooth extraction at the intended implant recipient site within the last 6 months.

  9. The use of regenerative procedures in conjunction with implant placement.

  10. Presence of residual roots at the implant recipient site.

  11. Stomatological diseases.

  12. Clinical signs of bruxism.

  13. Initial stability at least 35Ncm

Contacts and Locations

Locations

Site City State Country Postal Code
1 Loma Linda Health Loma Linda California United States 92350

Sponsors and Collaborators

  • Loma Linda University

Investigators

  • Principal Investigator: Aladdin j Alardah, DDS, associate professor

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Aladdin Al-Ardah, DDS, MS, Principal Investigator, Loma Linda University
ClinicalTrials.gov Identifier:
NCT02836964
Other Study ID Numbers:
  • 5160039
First Posted:
Jul 19, 2016
Last Update Posted:
Jun 16, 2017
Last Verified:
Jun 1, 2017
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes

Study Results

No Results Posted as of Jun 16, 2017